Chapter 8 Guideline for Evaluation of Off-label Uses

doi:10.3969/j.issn.1672-3384.2024.Z1.008

PDF(475 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (Z1) : 46-51. DOI: 10.3969/j.issn.1672-3384.2024.Z1.008

Guideline Consensus Clinical pathways

Chapter 8 Guideline for Evaluation of Off-label Uses

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(Z1): 46-51 https://doi.org/10.3969/j.issn.1672-3384.2024.Z1.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(475 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export